Investigator
Wei-Jun Qian
BATTELLE PACIFIC NORTHWEST LABORATORIES · funded by NIDDK
- Companies
- 3
- Grants
- 3
- Non-dilutive funding
- $5.0M
- First award
- Jul 21, 2023
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest May 1, 2026.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- BATTELLE PACIFIC NORTHWEST LABORATORIESMomentum in another area
ImmunologyGrant-only
- BATTELLE PACIFIC NORTHWEST LABORATORIESMomentum in another area
ImmunologyGrant-only
- BATTELLE PACIFIC NORTHWEST LABORATORIESMomentum in another area
ImmunologyGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- U01
Discovery of Pathways and Molecular Mediators of Early T1D Pathogenesis using Spatial Multi-Omics
$3.1MMay 1, 2026NIDDKBATTELLE PACIFIC NORTHWEST LABORATORIESNIH RePORTER · 11135130 (opens the source filing in a new tab)
- U01
Robust Mass Spectrometric Protein/Peptide Assays for Type 1 Diabetes Clinical Applications
$930kJul 21, 2023NIDDKBATTELLE PACIFIC NORTHWEST LABORATORIESNIH RePORTER · 11120936 (opens the source filing in a new tab)
- U01
Robust Mass Spectrometric Protein/Peptide Assays for Type 1 Diabetes Clinical Applications
$915kJul 21, 2023NIDDKBATTELLE PACIFIC NORTHWEST LABORATORIESNIH RePORTER · 11335733 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources